Trading Options with an Edge
Select Page

ALLO

Search by
TICKER SYMBOL

Allogene Therapeutics Inc

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

24.88

-0.5

(-1.97%)

Volume:

0

52 week range:

20.58 - 44.92

Market Cap:

3.538B

Company Description:

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of 'off-the-shelf' CAR T cell therapy candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.